Associations of immunological proteins/traits with schizophrenia, major depression and bipolar disorder: A bi-directional two-sample mendelian randomization study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Associations of immunological proteins/traits with schizophrenia, major depression and bipolar disorder: A bi-directional two-sample mendelian randomization study
Authors
Keywords
Mendelian randomization, Inflammation, Immune system, depression, schizophrenia, bipolar disorder
Journal
BRAIN BEHAVIOR AND IMMUNITY
Volume 97, Issue -, Pages 176-185
Publisher
Elsevier BV
Online
2021-07-17
DOI
10.1016/j.bbi.2021.07.009
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology
- (2021) Niamh Mullins et al. NATURE GENETICS
- Minimal phenotyping yields genome-wide association signals of low specificity for major depression
- (2020) Na Cai et al. NATURE GENETICS
- Interleukin-6 Signaling Effects on Ischemic Stroke and other Cardiovascular Outcomes: A Mendelian Randomization Study
- (2020) Marios K. Georgakis et al. Circulation-Genomic and Precision Medicine
- Dissecting the Association Between Inflammation, Metabolic Dysregulation, and Specific Depressive Symptoms
- (2020) Nils Kappelmann et al. JAMA Psychiatry
- Longitudinal association between depression and inflammatory markers: results from the NESDA study
- (2019) Femke Lamers et al. BIOLOGICAL PSYCHIATRY
- Shared mechanisms between coronary heart disease and depression: findings from a large UK general population-based cohort
- (2019) Golam M. Khandaker et al. MOLECULAR PSYCHIATRY
- The Role of BDNF in the Neuroimmune Axis Regulation of Mood Disorders
- (2019) Yang Jin et al. Frontiers in Neurology
- Assessing causal links between metabolic traits, inflammation and schizophrenia: a univariable and multivariable, bidirectional Mendelian-randomization study
- (2019) Bochao D Lin et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Profiling inflammatory signatures of schizophrenia: A cross-sectional and meta-analysis study
- (2018) Dorota Frydecka et al. BRAIN BEHAVIOR AND IMMUNITY
- The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally?
- (2018) Teizo Yoshimura Cellular & Molecular Immunology
- Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression
- (2018) Naomi R. Wray et al. NATURE GENETICS
- Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases
- (2018) Marie Verbanck et al. NATURE GENETICS
- Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection
- (2018) Antonio F. Pardiñas et al. NATURE GENETICS
- Childhood and Parental Asthma, Future Risk of Bipolar Disorder and Schizophrenia Spectrum Disorders: A Population-Based Cohort Study
- (2018) Qiong Wu et al. SCHIZOPHRENIA BULLETIN
- The MR-Base platform supports systematic causal inference across the human phenome
- (2018) Gibran Hemani et al. eLife
- Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder: systematic review and meta-analyses
- (2018) Tobias Rowland et al. BRITISH JOURNAL OF PSYCHIATRY
- The neurobiological hypothesis of neurotrophins in the pathophysiology of schizophrenia: A meta-analysis
- (2018) Daniela Rodrigues-Amorim et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Protocol for the insight study: a randomised controlled trial of single-dose tocilizumab in patients with depression and low-grade inflammation
- (2018) Golam M Khandaker et al. BMJ Open
- Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders
- (2018) Symen Ligthart et al. AMERICAN JOURNAL OF HUMAN GENETICS
- A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Tocilizumab, An Interleukin-6 Receptor Antibody, For Residual Symptoms in Schizophrenia
- (2017) Ragy R Girgis et al. NEUROPSYCHOPHARMACOLOGY
- Meta-analysis of Cerebrospinal Fluid Cytokine and Tryptophan Catabolite Alterations in Psychiatric Patients: Comparisons Between Schizophrenia, Bipolar Disorder, and Depression
- (2017) Alexandre K Wang et al. SCHIZOPHRENIA BULLETIN
- Inflammatory Biomarkers and Risk of Schizophrenia
- (2017) Fernando Pires Hartwig et al. JAMA Psychiatry
- The role of interleukin-6 signaling in nervous tissue
- (2016) Michelle Rothaug et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Selecting instruments for Mendelian randomization in the wake of genome-wide association studies
- (2016) Daniel I Swerdlow et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression
- (2016) D R Goldsmith et al. MOLECULAR PSYCHIATRY
- Childhood interleukin-6, C-reactive protein and atopic disorders as risk factors for hypomanic symptoms in young adulthood: a longitudinal birth cohort study
- (2016) J. F. Hayes et al. PSYCHOLOGICAL MEDICINE
- Th9 and other IL-9-producing cells in allergic asthma
- (2016) Sonja Koch et al. Seminars in Immunopathology
- Multivariable Mendelian Randomization: The Use of Pleiotropic Genetic Variants to Estimate Causal Effects
- (2015) S. Burgess et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants: Fig. 1.
- (2015) Mitchell J. Machiela et al. BIOINFORMATICS
- IL-6 as a keystone cytokine in health and disease
- (2015) Christopher A Hunter et al. NATURE IMMUNOLOGY
- Depression and the risk of autoimmune disease: a nationally representative, prospective longitudinal study
- (2015) N. W. Andersson et al. PSYCHOLOGICAL MEDICINE
- Association of Serum Interleukin 6 and C-Reactive Protein in Childhood With Depression and Psychosis in Young Adult Life
- (2014) Golam M. Khandaker et al. JAMA Psychiatry
- Efficient Design for Mendelian Randomization Studies: Subsample and 2-Sample Instrumental Variable Estimators
- (2013) B. L. Pierce et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Elevated C-Reactive Protein, Depression, Somatic Diseases, and All-Cause Mortality: A Mendelian Randomization Study
- (2013) Marie Kim Wium-Andersen et al. BIOLOGICAL PSYCHIATRY
- Functional IL6R 358Ala Allele Impairs Classical IL-6 Receptor Signaling and Influences Risk of Diverse Inflammatory Diseases
- (2013) Ricardo C. Ferreira et al. PLoS Genetics
- Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
- (2012) LANCET
- The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
- (2012) LANCET
- A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression
- (2012) Charles L. Raison et al. JAMA Psychiatry
- IL-2: A two-faced master regulator of autoimmunity
- (2011) Rahul Sharma et al. JOURNAL OF AUTOIMMUNITY
- Genetics of serum BDNF: Meta-analysis of the Val66Met and genome-wide association study
- (2011) Antonio Terracciano et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants
- (2010) Brandon L Pierce et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis
- (2010) M J Green et al. MOLECULAR PSYCHIATRY
- Major Depression and Coronary Artery Disease in the Swedish Twin Registry
- (2009) Kenneth S. Kendler et al. ARCHIVES OF GENERAL PSYCHIATRY
- Long-Term Interleukin-6 Levels and Subsequent Risk of Coronary Heart Disease: Two New Prospective Studies and a Systematic Review
- (2008) John Danesh et al. PLOS MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now